| Literature DB >> 34885763 |
Agnieszka Drzewiecka-Matuszek1, Dorota Rutkowska-Zbik1.
Abstract
An important focus for innovation in photodynamic therapy (PDT) is theoretical investigations. They employ mostly methods based on Time-Dependent Density Functional Theory (TD-DFT) to study the photochemical properties of photosensitizers. In the current article we review the existing state-of-the-art TD-DFT methods (and beyond) which are employed to study the properties of porphyrinoid-based systems. The review is organized in such a way that each paragraph is devoted to a separate aspect of the PDT mechanism, e.g., correct prediction of the absorption spectra, determination of the singlet-triplet intersystem crossing, and interaction with molecular oxygen. Aspects of the calculation schemes are discussed, such as the choice of the most suitable functional and inclusion of a solvent. Finally, quantitative structure-activity relationship (QSAR) methods used to explore the photochemistry of porphyrinoid-based systems are discussed.Entities:
Keywords: photodynamic therapy (PDT); porphyrinoids; time-dependent density functional theory (TD-DFT)
Mesh:
Substances:
Year: 2021 PMID: 34885763 PMCID: PMC8658767 DOI: 10.3390/molecules26237176
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1The scheme of photodynamic therapy.
Scheme 2Gouterman’s model of porphyrinoids’ main absorption bands (note that substitution or other modifications in the porphyrin skeleton may result in modification of orbital levels, causing changes in the band assignment).
The mean errors (ME), the mean absolute errors (MAE), and absolute maximum errors (MAXE) determined by comparing theoretical (RPA approach, def2-SVP basis set) and experimental spectra of various porphyrinoids (porphyrin, octaethylporphyrin, Mg octaethylporphyrin, Zn octaethylporphyrin, tetraphenylporphyrin, Mg tetraphenylporphyrin, Zn tetraphenylporphyrin, tetrakis(o-aminophenyl)porphyrin, Zn tetrakis(4-carboxyphenyl)porphyrin, Zn [5,15-dipiridyl- 10,20-bis(pentafluorophenyl)] porphyrin, Zn [5,15-di(pyridylacetyl)-0,20-diphenyl] porphyrin, octabromotetraphenyl porphyrin) determined with different functionals—data taken from [83].
| Functional | ME [eV] | MAE [eV] | MAXE [eV] |
|---|---|---|---|
| GGA and meta-GGA functionals | |||
| PBE | −0.04 | 0.11 | 0.48 |
| BP89 | −0.04 | 0.11 | 0.47 |
| BLYP | −0.05 | 0.10 | 0.46 |
| TPSS | 0.00 | 0.10 | 0.38 |
| M06-L | 0.05 | 0.11 | 0.26 |
| Global hybrid functionals | |||
| PBE0 | 0.15 | 0.15 | 0.25 |
| B3P86 | 0.13 | 0.13 | 0.24 |
| B3LYP | 0.12 | 0.12 | 0.23 |
| TPSS0 | 0.16 | 0.16 | 0.27 |
| M06 | 0.07 | 0.10 | 0.17 |
| BHLYP | 0.14 | 0.14 | 0.22 |
| M06-2X | 0.15 | 0.15 | 0.23 |
| Range separated hybrid functionals | |||
| ωB97 | −0.16 | 0.16 | 0.23 |
| ωB97X | −0.08 | 0.09 | 0.17 |
| LC-BLYP | −0.09 | 0.10 | 0.18 |
| CAM-B3LYP | 0.07 | 0.08 | 0.16 |
Performances of the CAM-B3LYP functional when reproducing experimental Q and B bands of selected porphyrinoids.
| System | Basis-Set | Q [nm] | B [nm] | Exp. [nm] | Ref. |
|---|---|---|---|---|---|
| H2P (free-base porphyrin) | 6-31G | 502 | 331 | Q 514 | [ |
| Zn-P | 6-31G | 512 | 334 | Q 569–532 | [ |
| Zn-P | 6-31G(d) | 517 | 335 | Q 572 | [ |
| Zn-TPP | 6-31G(d) | 541 | 359 | Q 586 | [ |
| 5,10,15,20-tetrakis(4-hydroxyphenyl)-porphyrin (p-THPP) | 6-31G** | Qy 590 | n/d | Qy 651, 594 | [ |
| Phtalocyanine (Pcs) | 6-311G(d,p) | Qy 624 | 295 | Qy 654 | [ |
| Zn-Pcs | 6-311G(d,p) | 612 | 296 | Q 667 | [ |
| Zn-Pcs | 6-31G(d) | 607 | 313, 295 | Q 670 | [ |
Performances of the B3LYP functional when reproducing experimental Q and B bands of selected porphyrinoids.
| System | Basis-Set | Q [nm] | B [nm] | Exp. [nm] | Ref. |
|---|---|---|---|---|---|
| H2P (free-base porphyrin) | 6-31G | 500 | 348 | Q 514 | [ |
| Zn-P | 6-31G | 506 | 347 | Q 569-532 | [ |
| Zn-P | 6-31G(d) | 507 | 349 | Q 572 | [ |
| Zn-TPP | 6-31G(d) | 535 | 381 | Q 586 | [ |
| 6-31G(d) | Qy 599.01 | 435.12; 431.77; 425.25; 423.87; 407.23 | Qy 651,594 | [ | |
| 6-31G(d) | 594, 571 | n/d | 656, 624, 583 | [ | |
| 5,10,15,20-tetrakis- (m-hydroxyphenyl)chlorin (m-THPC, Foscan) | 6-311+G(d,p) | 558, 523 | n/d | 650, 414 | [ |
| 5,10,15,20-tetrakis(4-hydroxyphenyl)-porphyrin (p-THPP) | 6-31G | Qy 587 | n/d | Qy 651, 594 | [ |
| p-THPP | 6-31G** | Qy 588 | n/d | Qy 651, 594 | [ |
| p-THPP | 6-31G+** | Qy 585 | n/d | Qy 651, 594 | [ |
| B-ring benzoporphyrin derivative B3B− | 6-311+G(d,p) | Qy 626 | 442, 437, 409 | Qy 689, 628 | [ |
| B-ring benzoporphyrin derivative B3B0 | 6-311+G(d,p) | Qy 636 | 474, 466, 412, 403 | Qy 688, 628 | [ |
| B-ring benzoporphyrin derivative B3B2+ | 6-311+G(d,p) | Qy 668 | 467, 460, 430, 419 | Qy 672,616 | [ |
| Phtalocyanine (Pcs) | 6-311G(d,p) | Qy 602 | 328 | Qy 654 | [ |
| Zn-Pcs | 6-311G(d,p) | 596 | 323 | Q 667 | [ |
| Zn-Pcs | 6-31G(d) | 593 | 366, 338 | Q 670 | [ |